期刊文献+

胃良恶性病变组织中CHK1和PLK1的表达及意义 被引量:4

Expression of checkpoint kinase 1 and polo-like kinase 1 and its clinicopathological significance in benign and malignant lesions of the stomach
下载PDF
导出
摘要 目的:研究胃良恶性病变组织中细胞周期检测点激酶1(CHK1)和Polo样激酶1(PLK1)的表达水平及其临床病理意义。方法:收集59例胃癌、20例癌旁组织、42例淋巴结转移灶及95例不同类型胃良性病变(浅表性胃炎20例,萎缩性胃炎20例,胃溃疡20例,胃息肉35例),手术切除或胃镜活检标本常规制作石蜡包埋切片。采用EnvisionTM免疫组织化学法检测CHK1和PLK1的表达。结果:胃癌组织CHK1表达阳性率明显高于各类型胃良性病组织(P<0.01);胃癌PLK1表达阳性率明显高于癌旁组织(P<0.05)和各类型胃良性病变组织(P<0.01),且PLK1阳性表达的胃良性病变均呈不典型增生;CHK1和PLK1在淋巴结转移灶和其相应原发灶中表达无明显差异(P>0.05);组织学分级II级病例CHK1表达阳性率明显低于组织学分级III+IV级(P<0.05);无淋巴结转移病例CHK1和PLK1表达阳性率明显低于淋巴结转移病例(P<0.05);胃癌组织中CHK1和PLK1表达存在相关性(P<0.05)。结论:CHK1和PLK1表达水平可能是反映胃癌发生、进展、生物学行为及指导临床辅助治疗的重要激酶类生物学指标。 Objective To determine the expressive level of checkpoint kinase 1 (CHK1) and polo-like kinase 1 (PLK1) and to detect their clinicopathological significance in benign and malignant lesions of the stomach.Methods Envision Tm immunohistochemistry was used to detect the expression level of CHK1 and PLK1 in conventional paraffin-embedded sections from specimens of primary foci (n=59)and metastatic foci of lymph node (n=42) of gastric cancer,peritumoral tissues (n=20),and benign lesions of the stomach (n=95). Results The positive rates of CHK1 were significantly higher in gastric cancer than that in different types of benign lesions(P0.01). The positive rates of PLK1 were significantly higher in gastric cancer than that in peritumoral tissues (P0.05) and different types of benign lesions (P0.01),and the positive cases of PLK1 in benign lesion showed atypical hyperplasia. No significant difference of CHK1 and PLK1 expression was found between metastatic foci and corresponding primary foci (P0.05). The positive rates of CHK1 and PLK1 were significantly lower in the non-metastatic lymph node than that in the metastatic lymph node (P0.05). The positive rate of CHK1 was significantly lower in histologic gradeⅡthan that in the histologic gradeⅢ+Ⅳ(P0.05). Positive correlation was found between the expression of CHK1 and PLK1 in gastric cancer tissues (P0.01). Conclusion The expression level of CHK1 and /or PLK1 might be important biological markers of kinases to reflect the carcinogenesis,progression,biological behaviors,and guide clinical auxiliary treatment of gastric cancer.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2010年第10期1080-1084,共5页 Journal of Central South University :Medical Science
关键词 胃肿瘤 胃疾病 细胞周期检测点激酶1 POLO样激酶1 免疫组织化学 stomach neoplasms stomach diseases checkpoint kinase 1 polo-like kinase 1 immunohistochemistry
  • 相关文献

参考文献17

  • 1Bartek J,Lukas J.Chk1 and chk2 kinases in checkpoint control and cancer[J].Cancer Cell,2003,3(5):421-429.
  • 2Senderowicz A M.Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms[J].Cancer Chemother Pharmacol,2003,52(suppl):s61-s73.
  • 3Zhang W H,Poh A,Fanous A A,et al.DNA damage-induced S phase arrest in human breast cancer depends on chk1,but G2 arrest can occur independently of chk1,chk2 or MAPKAPK2[J].Cell Cycle,2008,7(11):1668-1677.
  • 4Verlinden L,Vande Bempt I,Eelen G,et al,The E2F-regulated gene chk1 is highly expressed in triple-negative estrogen receptor/progesterone receptor/HER-2 breast carcinomas[J].Cancer Res,2007,67(14):6574-6581.
  • 5Matsumoto K,Nagahara T,Okano J,et al.The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases[J].Oncol Rep,2008,20(4):863-872.
  • 6Menoyo O A,Alazzouzi H,Espin E,et al.Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microstatellite instability[J].Cancer Res,2001,61(21):7727-7730.
  • 7马全富,黄晓园,高庆蕾,庄亮,曹阳,卢运萍,周剑锋,马丁.Chk1/2和Plk1蛋白在子宫内膜癌中的表达[J].肿瘤防治研究,2008,35(6):424-426. 被引量:12
  • 8Malumbres M,Barbacid M.Cell cycle kinases in cancer[J].Curr Opin Genet Dev,2007,17(1):60-65.
  • 9Martin B T,Strebhardt K.Polo-like kinase1:target and regulator of transcriptional control[J].Cell Cycle,2006,5(24):2881-2885.
  • 10Wang X Q,Zhu Y Q,Luis K S,et al.Aberrant polo-like kinasel-cdc25A pathway in metastatic hepatocellular carcinoma[J].Clin Cancer Res,2008,14(21):6813-6820.

二级参考文献6

  • 1American Cancer Society. Cancer facts and figures 2005[M]. Atlanta: Ga. American Cancer Socirty, 2005. 122-124.
  • 2Bartek J, Lukas J. Chkl and Chk2 kinases in checkpoint control and cancer[J]. Cancer Cell, 2003, 3(5) : 421-429.
  • 3Smits VA, KlompmakerR, Arnaud L, et al. Polo-like kinase-1 is a target of the DNA damage checkpoinl[J]. Nat Cell Biol. 2000, 2(9): 672-676.
  • 4Zhou BB, Bartek J. Targeting the checkpoint kinases: hemosensitization versus ehemoprotection[J]. Nat Rev Cancer, 2004, 4(3) :216-225.
  • 5Takai N, Hamanaka R, Yoshimatsu J, et al. Polo-like kinases (Plks) and cancer[J]. Oncogene,2005, 24(2): 287-291.
  • 6Weichert W, Denkert C, Schmidt M, et al. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma [J]. Br J Cancer. 2004, 90(4) : 815-821.

共引文献11

同被引文献37

  • 1王玉祥,祝淑钗,王鑫,封巍,李娟,沈文斌.CHK1和CHK2在食管癌组织中的表达[J].肿瘤防治研究,2006,33(3):171-174. 被引量:10
  • 2王玉祥,祝淑钗,封巍,李娟,苏景伟,李任.CHK1和CHK2 shRNA转染对食管癌细胞照射后G_2期阻滞的影响[J].中华肿瘤杂志,2006,28(8):572-577. 被引量:15
  • 3黄晓园,高庆蕾,庄亮,曹阳,马全富,周剑峰,马丁.Chk1/2和Plk1蛋白在宫颈良恶性病变组织中的表达及其意义[J].中国癌症杂志,2007,17(6):429-432. 被引量:12
  • 4Berg RW. Tumor growth inhibitionin vivoand GJM cell cy- cle arrest induced by antisense oligodeoxynucleotide target- ing thymidylate syn-thase [J]. J Pharmacol Exp Ther,2001, 298(2) :477.
  • 5陈忠民.PTEN通过抑制P13-AKT信号通路上调Rad51基因的表达[J].中国生物化学与分子生物学报,2009,2(24):192-194.
  • 6Krepela E. Expression of apoptosome pathway-related transcripts in non-small cell lung cancer [J]. J Cancer Res Clin Oncol, 2006,132 (1) : 57-68.
  • 7Connell PP. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers [J]. Int J Oncol, 2006,28 : 1113-1119.
  • 8Hannay JA. Rad51 overexpression conyributes to chem. Oresistance in hum an soft tissue sarcoma ceslls a role for p53/activator protein 2 transcriptional regulation [J]. Mol Cancer Ther,2007,6(5) :1650-1660.
  • 9Bahassi EM. The checkpoint kinase ehkl and ehk2 regu- late the functional associations between hBRCA2 and Rad51 in response to DNA damage [J]. Oncogene,2008, 27 (2) : 3977-3985.
  • 10Romanowicz-Makowska H,Smolarz B,Samulak D. A single nu-cleotide polymorphism in the 5'untranslated region of RAD51 and ovari-an cancer risk in Polish women[J].European Journal of gynaecological oncology,2012,(04):406-410.

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部